THE GLOBAL ANTI-SNORING DEVICES MARKET SIZE WAS VALUED AT USD 1.14 BILLION IN 2021 AND IS EXPECTED TO REACH USD 1.81 BILLION BY 2027, GROWING AT A CAGR OF 7.98% DURING THE FORECAST PERIOD

The Global Anti-Snoring Devices Market Size, Share, Growth Forecast by: 

  • Product: Oral Devices, Pap Devices, Nasal Devices, and Others
  • Age Group: Between 40 & 59 Years, 60 & Above Years, and Below 40 Years
  • Gender: Men and Women
  • End User: Sleep Labs & Dental Clinics, Home Healthcare, and Hospitals
  • Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

305 Pages

icon-table

174 Tables

icon-chart

147 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

31 Companies

icon-market

5 Market Segment

ANTI-SNORING DEVICES MARKET REPORT SCOPE

Report Attribute Details
Market Size (2027) USD 1.81 Billion
Market Size (2021) USD 1.14 Billion
CAGR (2022-2027) 7.98%
Base Year 2021
Forecast Year 2022-2027
Market Segments Product, Age Group, Gender, End User, and Geography
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
KEY VENDORS Apnea Science, ResMed, Koninklijke Philips N.V, Fisher & Paykel, and Tomed

MARKET ANALYSIS

The global anti-snoring devices market is estimated to reach USD 1.81 billion from USD 1.14 billion in 2021, growing at a CAGR of 7.98% from 2022-2027. The growth of the anti-snoring devices market is attributed to key factors such as a high prevalence of snoring, OSA, increasing awareness of adverse effects of snoring, technological advancements in anti-snoring devices, and an increasingly aging population. Chronic snoring causes many people (and their partners) to lose sleep. The most common cause of snoring is when the throat and tongue tissues become overly relaxed. The sound of snoring is made when air vibrates the tissue as it passes through.

The technological advancements have affected the anti-snoring market positively. Smart anti-snoring devices are part of the innovative concept, which involves creating the functionality of devices used daily and making them perform more than intended. Connectivity options using IoT, enabling these devices to be interconnected with other devices at home, have further increased their basic functions. During the forecast period, it is expected that the oral anti-snoring devices market will continue to grow much faster than the CPAP and other devices. This is because of the high patient adherence, as these are available at dentists and online channels, making it easy for manufacturers to market their products.

MARKET TRENDS & OPPRUTINITES

Emergence Of Smart Snoring Devices
Snoring is a common problem that affects not only individuals but also their partners. Most solutions available in the anti-snoring devices market, such as mouthguards, strips, and bands, are often uncomfortable for the wearer. To address this issue, medical technology start-ups are developing non-invasive anti-snoring devices. When these devices detect the sound of snoring, they gently move the snorer's head to restore normal breathing and stop snoring.

A Canadian company Smart Nora offers non-invasive anti-snoring solutions. This product consists of three parts: a Pebble device that detects snoring, a padded pillowcase, and a quiet pump that inflates and contracts the padded insert. When the initial snoring sound is detected, the pillow is moved. Movement stimulates the neck muscles, resumes natural breathing, and improves sleep quality. Signifier Medical Technologies offers new and innovative devices. eXciteOSA is a removable tongue muscle stimulation device that provides nerve muscle stimulation of the tongue to lower snoring and mild sleep apnea in patients over the age of 18.

New Launches and Approval of Anti-Snoring Devices
Sleep apnea treatment is very effective for patients due to increasing evidence that it improves symptoms, lowers blood pressure, improves glucose control, and reduces the risk of movement disorders. Because the consequences of the disease can be irreversible, it can create a strong case that early treatment may be beneficial, "says Atul Malhotra, M.D. Head of Sleep Medicine Research at the University of California, San Diego Health.

In May 2022, Illusion Aligners launched a new innovative anti-snoring device in the anti-snoring devices market. This Illusion Aligner oral anti-snoring device is easy to wear, effective, and comfortable. It helps the user to experience an undisturbed and peaceful sleep every night. The FDA has granted Signifier Medical Technologies, LLC marketing approval for eXcite OSA devices. In February 2021, Signifier Medical Technologies launched an innovative anti-snoring device, eXciteOSA. The device works by producing electrical muscle stimulation through a mouthpiece that lies around the tongue. The device has four electrodes, two located above the tongue and two below the tongue. GoodSmonia will also launch a Smart stop-snoring device in the anti-snoring devices market. The product helps increase blood flow and stimulates the muscle, toning the soft palate and making them tighter and stronger.

Technological Advances in Continuous Positive Airway Pressure (CPAP) Therapy
Continuous Positive Airway Pressure (CPAP) has changed significantly in the anti-snoring devices market since its inception in 1981. Devices developed decades ago were heavier, noisier, and had limited performance compared to today's slim, lightweight devices. An outstanding innovation is the Automatic Airway Pressure Device (AutoPAP). With AutoPAP, airway pressure begins with light to meet lower pressure needs. When a patient falls asleep, the device automatically adjusts to increase positive airway pressure and keep the respiratory system open. State-of-the-art CPAP and autoPAP machines include microprocessors that enable high-density data storage, internal self-tests to ensure that hardware and software are functioning properly, and patient usage specifics.

It contains several reports that can detail the parameters. This allows clinicians to track patient compliance and keep track of usage in an hourly, daily, weekly, or monthly format. The important thing is to get accurate daily usage. Compliance measurements are more accurate by recording mask-on-time instead of on-time (used in older CPAP models via a digital meter).

Another notable feature of CPAP today is its low noise level. In addition to size and weight, the CPAP machine's ability to deliver 20 cm H2O filtered air to patients with a slight hump is just as fresh for doctors, patients, and bed partners. The days of sleeping next to mechanically generated hurricanes are over, thanks to a lightweight blower well insulated with CPAP machines.

SEGMENTATION ANALYSIS

INSIGHTS BY PRODUCT
The global oral anti-snoring devices market reported a significant share of around 46.33%in 2021. The segment is estimated to be higher because Oral appliances are body-fitting dental mouthpieces that help advance the position of the jaw, tongue, and soft palate to keep air passages open. When using oral instruments, a patient needs to consult a dentist to optimize the suitability and location of the instruments.

Oral appliance therapy (OAT) comes in different styles and is based on several technologies like Mandibular Advancement Devices (MADs), tongue retaining devices, Herbst-style oral appliances, and other smart OAT. The MADs used to treat sleep apnea are like the many simple snoring devices listed here in that they move the jaw forward. Thermoplastic MAD can be created and adjusted at the patient's home.

OAT is growing at a faster rate of 8.44 CAGR; the device is most preferred by the patient group in which CPAP compliance is low. With increasing CPAP device noncompliance, patients are recommended to use oral OSA devices such as mandibular advancement devices, Tongue Retaining Devices, implants, etc. The OAT is showing emerging growth in the anti-snoring devices market.

INSIGHTS BY AGE GROUP
Among all age groups, between 40- & 59 years segments reported a major share of around 54.68% in 2021 in the global anti-snoring devices market. The segment is estimated to be higher because the 40-59 age group is the working adult population facing daily issues from the workplace to home. The major risk factors for developing OSA and its related symptoms, like snoring in this age group, are work-related stress, alcohol consumption, chronic smoking, and obesity.

According to a new study, “Mind the Workplace report” in 2022, released by Mental Health America (MHA), from more than 11,300 U.S. employees across 17 industries in 2021 showed, 71% found it difficult to concentrate at work, compared to 65% in 2020 and 46% in 2018.

The rapid shift towards being a 24/7 society that involves using the nighttime for activities contributes majorly to people's sleep cycle. This is mainly the result of rapid urbanization in developed and developing countries. Such practices induce unnecessary stress on the brain, thus making it harder to achieve ideal sleep. The increasing use of technology such as smartphones and television delay the sleeping time during the night, which also delays the waking up time. The 24/7 society is also encouraging the alternate shift approach, increasing sleeping problems in the working population.

INSIGHTS BY GENDER
The men segment dominates the global anti-snoring devices market with a most significant share of around 62.01%. The segment is estimated to be higher because obesity is associated with serious health risks. Severe obesity in men further increases the risk of obesity-related complications such as coronary artery disease and end-stage renal disease. According to the 2017 CDC Report-2018, the prevalence of obesity in men was 40.3% for ages 20-39, 46.4% for ages 40-59, and 42.2% for ages 60 & older. Among men, the highest prevalence of snoring was in the 50–59-year-old group, of which 19.5% had moderate snoring, and 14.6% had habitual snoring. 10.6% of men in the 55–69-year group had clinical suspicion of obstructive snoring sleep apnea.

INSIGHT BY END-USER
The sleep labs & dental clinics segment reported a significant share of around 43.07% in the global anti-snoring devices market in 2021. The segment is estimated to be higher because the sleep labs' services are in-lab testing and in-house or home sleep testing units. The diagnostic method is selected based on the disease condition and the patient’s convenience. Diagnostic devices used as a part of such service differ based on the location where the diagnosis is being performed. In-lab testing includes the use of PSG or polysomnography, which is considered a gold-standard diagnostics test.

Many people are unaware that dentists can play an important role in preventing snoring. The first line of therapy against snoring is often oral therapy with a splint. The customized sprint fits comfortably on teeth like a sports mouthguard. The dentist can fabricate a Mandibular Advancement Device (MAD) that slowly moves the mandible forward to a more favorable position and prevents soft tissue from blocking the airways.

GEOGRAPHICAL ANALYSIS

North America reported a significant share of around 33.31% among all regions in the global anti-snoring devices market. The region's market growth is favored by various factors, including the high prevalence of sleep disorders, decrease in sleep patterns, lifestyle changes, and presence of multiple vendors, including key players, start-ups, and sleep-based companies. The prevalence of OSA in North America is nearly 15 to 30% in men and 10 to 15% in women. The North American region has witnessed a high prevalence of OSA, snoring, and anti-snoring device manufacturers, which boosts the region's market share more than any other region in the world. The U.S. is the largest revenue generator country in the North American region due to lifestyle changes and the sedentary lifestyle of the country.

Asia Pacific (APAC) accounts for a 22.56% share in the global anti-snoring devices market and is estimated to reach USD 443.85% by 2027. APAC countries also witness a rapidly aging population, contributing to its increasing incidence of sleeping disorders. Mental health problems related to work stress, loneliness, and the impact of the pandemic on concentrating these issues have resulted in an increased number of cases in the region. The anti-snoring device market growth in this region is attributed to the manufacturing power of the countries involved in APAC, such as China, Japan, and India. Japan has one of the highest prevalence of mental health issues and one of the highest rates of work-related stress.

VENDOR LANDSCAPE

The global anti-snoring devices market is highly diversified, with several global and local players offering a diverse range of anti-snoring devices such as oral devices, PAP devices, nasal devices, and other devices. The market is consolidated with the global players accounting for high shares. Philips, ResMed, Fisher & Paykel, Apnea Sciences, and Tomed are the leading players that account for significant market shares.

The global players focus on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio. Manufacturers such as ResMed, Koninklijke Philips N.V, SomnoMed, and ProSomnus continuously focus on product development and offer sophisticated anti-snoring devices with new technology to increase their market presence.

Recent Developments

  • In May 2022, Illusion Aligners launched a new innovative anti-snoring device. This Illusion Aligner oral anti-snoring device is easy to wear, effective, and comfortable. It helps the user to experience an undisturbed and peaceful sleep every night.
  • In February 2021, Signifier Medical Technologies launched an innovative anti-snoring device, eXciteOSA, and the device works by producing electrical muscle stimulation through a mouthpiece around the tongue. The device has four electrodes, two located above the tongue and two below the tongue. The U.S. FDA approved the commercialization of a prescription-only anti-snoring device, ''eXciteOSA''.

Frequently Asked Questions

What is the size of the global anti-snoring devices market?

The global anti-snoring devices market size was valued at USD 1.14 billion in 2021 and is expected to reach USD 1.81 billion by 2027.

What is the global anti-snoring devices market growth rate?

The global anti-snoring devices market share is expected to grow at a CAGR of 7.98% from 2022 to 2027.

What are the trends driving the global anti-snoring devices market growth?

The emergence of smart anti-snoring devices, market entry of sleep-based start-up companies, the emergence of the latest generation of Herbst-style oral appliances, and new launches and approval of anti-snoring devices are some significant trends in the anti-snoring devices market.

Who are the key players in the global anti-snoring devices market?

Apnea Science, ResMed, Koninklijke Philips N.V, Fisher & Paykel, and Tomed are the leading global anti-snoring device market companies.

Which regions will likely dominate the global anti-snoring devices market during the 2021-2027?

North America will likely dominate the anti-snoring devices market during the forecast period. The region's market growth depends on various factors, including a high prevalence of sleep disorders, decreased sleep patterns, and lifestyle changes.

Download Free Sample

The global anti-snoring devices market is expected to grow at a CAGR of approximately 7.98% from 2022 to 2027.

The following factors are likely to contribute to the growth of the global anti-snoring devices market during the forecast period:

  • Increasing Purchase of Anti-Snoring Devices Through Online Pharmacies
  • Increasing Awareness of Snoring Adverse Effects
  • Increasing target patient population
  • Technological Advances in Continuous Positive Airway Pressure (CPAP) Therapy

Base Year: 2021

Forecast Year: 2022-2027

The report considers the present scenario of the global anti-snoring devices market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

Key Vendors

  • Apnea Science
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • ResMed
  • Koninklijke Philips N.V
  • Fisher & Paykel
  • Tomed

Other Prominent Vendors

  • Illusion Aligners
    • Business Overview
    • Product Offerings
  • Sleep Number
  • VVFLY Electronics
  • Signifier Medical Technologies
  • Glidewell
  • Smart Nora
  • ProSomnus
  • SomnoMed
  • REM-Fit
  • Downtown Denver Sleep Solutions
  • MEDITAS
  • ApneaMed
  • Wolfson Holdco
  • Rhinomed
  • DeVilbiss Healthcare
  • White Dental Healthcare
  • Hupnos
  • Nitetronic
  • Nyxoah
  • Oventus
  • Vivos Therapeutics
  • Somnowell
  • ZQuiet
  • RemSleep Holdings
  • Humetron
  • Nidra Care

Segmentation by Product

  • Oral Devices
  • Pap Devices
  • Nasal Devices
  • Others

Segmentation by Application

  • Body Contouring & Cellulite Reduction
  • Skin Tightening & Skin Lighteners
  • Facial Aesthetic
  • Breast Augmentation
  • Others

Segmentation by Age Group

  • Between 40 & 59 Years
  • 60 & Above Years
  • Below 40 Years

Segmentation by Gender

  • Men
  • Women

Segmentation by End User

  • Sleep Labs & Dental Clinics
  • Home Healthcare
  • Hospitals

Segmentation by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSION
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION

6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS

7.1 MARKET OVERVIEW
7.1.1 MARKET DYNAMICS INSIGHTS
7.1.2 ANTI-SNORING DEVICES: MARKET SEGMENTATION
7.1.3 VENDOR ANALYSIS

8 INTRODUCTION
8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS
9.1 EMERGENCE OF SMART ANTI-SNORING DEVICES
9.2 ENTRY OF SLEEP-BASED START-UPS
9.3 ADVENT OF LATEST-GENERATION HERBST-STYLE ORAL APPLIANCES
9.4 APPROVAL & LAUNCH OF LATEST ANTI-SNORING DEVICES

10 MARKET GROWTH ENABLERS
10.1 ONLINE PURCHASE OF ANTI-SNORING DEVICES
10.2 AWARENESS OF ADVERSE EFFECTS OF SNORING
10.3 LARGE TARGET PATIENT POPULATION
10.4 TECHNOLOGICAL ADVANCES IN CPAP THERAPY

11 MARKET RESTRAINTS
11.1 HIGH COST OF ADVANCED ANTI-SNORING DEVICES
11.2 AVAILABILITY OF SURGICAL OPTIONS TO TREAT SNORING
11.3 LOW PATIENT COMPLIANCE WITH CPAP THERAPY

12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 MARKET SIZE & FORECAST
12.1.2 INSIGHTS BY GEOGRAPHY
12.1.3 INSIGHTS BY PRODUCT
12.1.4 INSIGHTS BY AGE
12.1.5 INSIGHTS BY GENDER
12.1.6 INSIGHTS BY END-USER
12.2 FIVE FORCES ANALYSIS
12.2.1 THREAT OF NEW ENTRANTS
12.2.2 BARGAINING POWER OF SUPPLIERS
12.2.3 BARGAINING POWER OF BUYERS
12.2.4 THREAT OF SUBSTITUTES
12.2.5 COMPETITIVE RIVALRY

13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 ORAL DEVICES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 PAP DEVICES
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 NASAL DEVICES
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 OTHERS
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY

14 AGE
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 BETWEEN 40 & 59 YEARS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 60 YEARS & ABOVE
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 BELOW 40 YEARS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY

15 GENDER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 MEN
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 WOMEN
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY

16 END-USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 SLEEP LABS & DENTAL CLINICS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 HOME HEALTHCARE SETTINGS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 HOSPITALS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 NORTH AMERICA: PRODUCT SEGMENTATION
18.2.2 NORTH AMERICA: AGE SEGMENTATION
18.2.3 NORTH AMERICA: GENDER SEGMENTATION
18.2.4 NORTH AMERICA: END-USER SEGMENTATION
18.3 KEY COUNTRIES
18.3.1 US: MARKET SIZE & FORECAST
18.3.2 CANADA: MARKET SIZE & FORECAST

19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 EUROPE: PRODUCT SEGMENTATION
19.2.2 EUROPE: AGE SEGMENTATION
19.2.3 EUROPE: GENDER SEGMENTATION
19.2.4 EUROPE: END-USER SEGMENTATION
19.3 KEY COUNTRIES
19.3.1 GERMANY: MARKET SIZE & FORECAST
19.3.2 FRANCE: MARKET SIZE & FORECAST
19.3.3 UK: MARKET SIZE & FORECAST
19.3.4 ITALY: MARKET SIZE & FORECAST
19.3.5 SPAIN MARKET SIZE & FORECAST

20 ASIA PACIFIC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 APAC: PRODUCT SEGMENTATION
20.2.2 APAC: AGE SEGMENTATION
20.2.3 APAC: GENDER SEGMENTATION
20.2.4 APAC: END-USER SEGMENTATION
20.3 KEY COUNTRIES
20.3.1 CHINA: MARKET SIZE & FORECAST
20.3.2 JAPAN: MARKET SIZE & FORECAST
20.3.3 INDIA: MARKET SIZE & FORECAST
20.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.3.5 AUSTRALIA: MARKET SIZE & FORECAST

21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 LATIN AMERICA: PRODUCT SEGMENTATION
21.2.2 LATIN AMERICA: AGE SEGMENTATION
21.2.3 LATIN AMERICA: GENDER SEGMENTATION
21.2.4 LATIN AMERICA: END-USER SEGMENTATION
21.3 KEY COUNTRIES
21.3.1 BRAZIL: MARKET SIZE & FORECAST
21.3.2 MEXICO: MARKET SIZE & FORECAST
21.3.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.2.1 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
22.2.2 MIDDLE EAST & AFRICA: AGE SEGMENTATION
22.2.3 MIDDLE EAST & AFRICA: GENDER SEGMENTATION
22.2.4 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
22.3 KEY COUNTRIES
22.3.1 TURKEY: MARKET SIZE & FORECAST
22.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS

24 KEY COMPANY PROFILES
24.1 APNEA SCIENCES
24.1.1 BUSINESS OVERVIEW
24.1.2 APNEA SCIENCES IN GLOBAL ANTI-SNORING DEVICES MARKET
24.1.3 PRODUCT OFFERINGS
24.1.4 KEY STRATEGIES
24.1.5 KEY STRENGTHS
24.1.6 KEY OPPORTUNITIES
24.2 RESMED
24.2.1 BUSINESS OVERVIEW
24.2.2 RESMED IN GLOBAL ANTI-SNORING DEVICES MARKET
24.2.3 PRODUCT OFFERINGS
24.2.4 KEY STRATEGIES
24.2.5 KEY STRENGTHS
24.2.6 KEY OPPORTUNITIES
24.3 KONINKLIJKE PHILIPS N.V
24.3.1 BUSINESS OVERVIEW
24.3.2 KONINKLIJKE PHILIPS N. V. IN GLOBAL ANTI-SNORING DEVICE MARKET
24.3.3 PRODUCT OFFERINGS
24.3.4 KEY STRATEGIES
24.3.5 KEY STRENGTHS
24.3.6 KEY OPPORTUNITIES
24.4 FISHER & PAYKEL HEALTHCARE
24.4.1 BUSINESS OVERVIEW
24.4.2 FISHER & PAYKEL HEALTHCARE IN GLOBAL ANTI-SNORING DEVICE MARKET
24.4.3 PRODUCT OFFERINGS
24.4.4 KEY STRATEGIES
24.4.5 KEY STRENGTHS
24.4.6 KEY OPPORTUNITIES
24.5 TOMED
24.5.1 BUSINESS OVERVIEW
24.5.2 TOMED IN GLOBAL ANTI-SNORING DEVICE MARKET
24.5.3 PRODUCT OFFERINGS
24.5.4 KEY STRATEGIES
24.5.5 KEY STRENGTHS
24.5.6 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS
25.1 ILLUSION ALIGNERS
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 SLEEP NUMBER
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 VVFLY ELECTRONICS
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 SIGNIFIER MEDICAL TECHNOLOGIES
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 GLIDEWELL
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 SMART NORA
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 PROSOMNUS
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 SOMNOMED
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 REM-FIT
25.9.1 BUSINESS OVERVIEW
25.9.2 PRODUCT OFFERINGS
25.10 DOWNTOWN DENVER SLEEP SOLUTIONS
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 MEDITAS
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 APNEAMED
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 WOLFSON HOLDCO
25.13.1 BUSINESS OVERVIEW
25.13.2 PRODUCT OFFERINGS
25.14 RHINOMED
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
25.15 DEVILBISS HEALTHCARE
25.15.1 BUSINESS OVERVIEW
25.15.2 PRODUCT OFFERINGS
25.16 WHITE DENTAL HEALTHCARE
25.16.1 BUSINESS OVERVIEW
25.16.2 PRODUCT OFFERINGS
25.17 HÜPNOS
25.17.1 BUSINESS OVERVIEW
25.17.2 PRODUCT OFFERINGS
25.18 NITETRONIC
25.18.1 BUSINESS OVERVIEW
25.18.2 PRODUCT OFFERINGS
25.19 NYXOAH
25.19.1 BUSINESS OVERVIEW
25.19.2 PRODUCT OFFERINGS
25.20 OVENTUS
25.20.1 BUSINESS OVERVIEW
25.20.2 PRODUCT OFFERINGS
25.21 VIVOS THERAPEUTICS
25.21.1 BUSINESS OVERVIEW
25.21.2 PRODUCT OFFERINGS
25.22 SOMNOWELL
25.22.1 BUSINESS OVERVIEW
25.22.2 PRODUCT OFFERINGS
25.23 ZQUIET
25.23.1 BUSINESS OVERVIEW
25.23.2 PRODUCT OFFERINGS
25.24 REMSLEEP HOLDINGS
25.24.1 BUSINESS OVERVIEW
25.24.2 PRODUCT OFFERINGS
25.25 HUMETRON
25.25.1 BUSINESS OVERVIEW
25.25.2 PRODUCT OFFERINGS
25.26 NIDRA CARE
25.26.1 BUSINESS OVERVIEW
25.26.2 PRODUCT OFFERINGS

26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY
27.1 MARKET BY PRODUCT
27.1.1 NORTH AMERICA
27.1.2 EUROPE
27.1.3 APAC
27.1.4 LATIN AMERICA
27.1.5 MIDDLE EAST & AFRICA
27.2 MARKET BY AGE
27.2.1 NORTH AMERICA
27.2.2 EUROPE
27.2.3 APAC
27.2.4 LATIN AMERICA
27.2.5 MIDDLE EAST & AFRICA
27.3 MARKET BY GENDER
27.3.1 NORTH AMERICA
27.3.2 EUROPE
27.3.3 APAC
27.3.4 LATIN AMERICA
27.3.5 MIDDLE EAST & AFRICA
27.4 MARKET BY END-USER
27.5 NORTH AMERICA
27.5.1 EUROPE
27.5.2 APAC
27.5.3 LATIN AMERICA
27.5.4 MIDDLE EAST & AFRICA
27.6 MARKET BY GEOGRAPHY
27.6.1 ORAL DEVICES
27.6.2 PAP DEVICES
27.6.3 NASAL DEVICES
27.6.4 OTHERS
27.6.5 BETWEEN 40 & 59 YEARS
27.6.6 60 YEARS & ABOVE
27.6.7 BELOW 40 YEARS
27.6.8 MEN
27.6.9 WOMEN
27.6.10 SLEEP LABS & DENTAL CLINICS
27.6.11 HOME HEALTHCARE SETTINGS
27.6.12 HOSPITALS

28 APPENDIX
28.1 ABBREVIATIONS

EXHIBIT 1 SEGMENTATION OF GLOBAL ANTI-SNORING DEVICES MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 RISK FACTORS FOR SNORING
EXHIBIT 4 GLOBAL ANTI-SNORING DEVICES MARKET (2021–2027)
EXHIBIT 5 POPULAR SMART ANTI-SNORING DEVICES
EXHIBIT 6 GLOBAL ANTI-SNORING DEVICES: MARKET SEGMENTATION
EXHIBIT 7 SYMPTOMS OF OBSTRUCTIVE SLEEP APNEA: US
EXHIBIT 8 RISK FACTORS FOR SNORING
EXHIBIT 9 IMPACT OF EMERGENCE OF SMART ANTI-SNORING DEVICES
EXHIBIT 10 POPULAR SMART ANTI-SNORING DEVICES
EXHIBIT 11 IMPACT OF ENTRY OF SLEEP-BASED START-UPS
EXHIBIT 12 START-UP ANTI-SNORING DEVICE COMPANIES
EXHIBIT 13 IMPACT OF ADVENT OF LATEST-GENERATION HERBST-STYLE ORAL APPLIANCES
EXHIBIT 14 LATEST GENERATION OF HERBST-STYLE ORAL APPLIANCES
EXHIBIT 15 IMPACT OF APPROVAL & LAUNCH OF LATEST ANTI-SNORING DEVICES
EXHIBIT 16 LAUNCH OF NEW ANTI-SNORING DEVICES
EXHIBIT 17 IMPACT OF ONLINE PURCHASE OF ANTI-SNORING DEVICES
EXHIBIT 18 IMPACT OF AWARENESS OF ADVERSE EFFECTS OF SNORING
EXHIBIT 19 ADVERSE EFFECTS OF SNORING
EXHIBIT 20 ADVERSE EFFECTS OF SNORING REPORTED: GUANGDONG PROVINCE (2017)
EXHIBIT 21 IMPACT OF LARGE TARGET PATIENT POPULATION
EXHIBIT 22 TYPE 2 DIABETES STATISTICS (2019–2045) (MILLION)
EXHIBIT 23 PREDIABETES STATISTICS (2019–2045) (MILLION)
EXHIBIT 24 GLOBAL OBESITY STATISTICS
EXHIBIT 25 IMPACT OF TECHNOLOGICAL ADVANCES IN CPAP THERAPY
EXHIBIT 26 IMPACT OF HIGH COST OF ADVANCED ANTI-SNORING DEVICES
EXHIBIT 27 IMPACT OF AVAILABILITY OF SURGICAL OPTIONS TO TREAT SNORING
EXHIBIT 28 IMPACT OF LOW PATIENT COMPLIANCE WITH CPAP THERAPY
EXHIBIT 29 GLOBAL ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 30 GLOBAL ANTI-SNORING DEVICES MARKET BY GEOGRAPHY: MARKET SHARE 2021 & 2027
EXHIBIT 31 GLOBAL ANTI-SNORING DEVICES MARKET BY PRODUCT: MARKET SHARE 2021 & 2027
EXHIBIT 32 GLOBAL ANTI-SNORING DEVICES MARKET BY AGE: MARKET SHARE 2021 & 2027
EXHIBIT 33 GLOBAL ANTI-SNORING DEVICES MARKET BY GENDER: MARKET SHARE 2021 & 2027
EXHIBIT 34 GLOBAL ANTI-SNORING DEVICES MARKET BY END-USER: MARKET SHARE 2021 & 2027
EXHIBIT 35 FIVE FORCES ANALYSIS 2021
EXHIBIT 36 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 37 GLOBAL ANTI-SNORING DEVICES MARKET BY PRODUCT
EXHIBIT 38 GLOBAL ANTI-SNORING DEVICES MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 39 GLOBAL ANTI-SNORING DEVICES MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL ANTI-SNORING DEVICES MARKET BY ORAL DEVICES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 41 TYPES OF MADS
EXHIBIT 42 GLOBAL ANTI-SNORING DEVICES MARKET BY ORAL DEVICES 2021–2027 ($ MILLION)
EXHIBIT 43 GLOBAL ANTI-SNORING DEVICES MARKET BY PAP DEVICES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 44 FEATURES OF APAP DEVICES
EXHIBIT 45 GLOBAL ANTI-SNORING DEVICES MARKET BY PAP DEVICES 2021–2027 ($ MILLION)
EXHIBIT 46 GLOBAL ANTI-SNORING DEVICE MARKET BY NASAL DEVICES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 47 GLOBAL ANTI-SNORING DEVICES MARKET BY NASAL DEVICES 2021–2027 ($ MILLION)
EXHIBIT 48 GLOBAL ANTI-SNORING DEVICES MARKET BY OTHERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL ANTI-SNORING DEVICES MARKET BY OTHERS 2021–2027 ($ MILLION)
EXHIBIT 50 INCREMENTAL GROWTH BY AGE 2021 & 2027
EXHIBIT 51 GLOBAL ANTI-SNORING DEVICES MARKET BY AGE
EXHIBIT 52 GLOBAL ANTI-SNORING DEVICES MARKET BY AGE: INCREMENTAL GROWTH
EXHIBIT 53 GLOBAL ANTI-SNORING DEVICES MARKET BY AGE: ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL ANTI-SNORING DEVICES MARKET BY BETWEEN 40 & 59 YEARS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL ANTI-SNORING DEVICES MARKET BY BETWEEN 40 & 59 YEARS 2021–2027 ($ MILLION)
EXHIBIT 56 GLOBAL ANTI-SNORING DEVICES MARKET BY 60 YEARS & ABOVE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL ANTI-SNORING DEVICES MARKET BY 60 YEARS & ABOVE 2021–2027 ($ MILLION)
EXHIBIT 58 COMMON CAUSES OF SNORING IN CHILDREN
EXHIBIT 59 GLOBAL ANTI-SNORING DEVICES MARKET BY BELOW 40 YEARS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 60 GLOBAL ANTI-SNORING DEVICES MARKET BY BELOW 40 YEARS 2021–2027 ($ MILLION)
EXHIBIT 61 INCREMENTAL GROWTH BY GENDER 2021 & 2027
EXHIBIT 62 GLOBAL ANTI-SNORING DEVICES MARKET BY GENDER
EXHIBIT 63 GLOBAL ANTI-SNORING DEVICES MARKET BY GENDER: INCREMENTAL GROWTH
EXHIBIT 64 GLOBAL ANTI-SNORING DEVICES MARKET BY GENDER: ABSOLUTE GROWTH
EXHIBIT 65 GLOBAL PERCENTAGE SHARE OF SNORING IN ADULT MEN
EXHIBIT 66 GLOBAL ANTI-SNORING DEVICES MARKET BY MEN: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 67 GLOBAL ANTI-SNORING DEVICES MARKET BY MEN 2021–2027 ($ MILLION)
EXHIBIT 68 GLOBAL ANTI-SNORING DEVICES MARKET BY WOMEN: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 69 GLOBAL ANTI-SNORING DEVICES MARKET BY WOMEN 2021–2027 ($ MILLION)
EXHIBIT 70 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 71 GLOBAL ANTI-SNORING DEVICES MARKET BY END-USER
EXHIBIT 72 GLOBAL ANTI-SNORING DEVICES MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 73 GLOBAL ANTI-SNORING DEVICES MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 74 GLOBAL ANTI-SNORING DEVICES MARKET BY SLEEP LABS & DENTAL CLINICS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 75 GLOBAL ANTI-SNORING DEVICES MARKET BY SLEEP LABS & DENTAL CLINICS 2021–2027 ($ MILLION)
EXHIBIT 76 GLOBAL ANTI-SNORING DEVICES MARKET BY HOME HEALTHCARE SETTINGS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 77 GLOBAL ANTI-SNORING DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021–2027 ($ MILLION)
EXHIBIT 78 GLOBAL ANTI-SNORING DEVICES MARKET BY HOSPITALS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 79 GLOBAL ANTI-SNORING DEVICES MARKET BY HOSPITALS 2021–2027 ($ MILLION)
EXHIBIT 80 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 81 GLOBAL ANTI-SNORING DEVICES MARKET BY GEOGRAPHY
EXHIBIT 82 GLOBAL ANTI-SNORING DEVICES MARKET BY GEOGRAPHY: KEY COUNTRIES
EXHIBIT 83 GLOBAL ANTI-SNORING DEVICES MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 84 GLOBAL ANTI-SNORING DEVICES MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 85 US SLEEP DEPRIVATION STATISTICS (2021)
EXHIBIT 86 NORTH AMERICA ANTI-SNORING DEVICES MARKET: KEY COUNTRIES
EXHIBIT 87 NORTH AMERICA ANTI-SNORING DEVICES MARKET: INCREMENTAL GROWTH ABSOLUTE GROWTH
EXHIBIT 88 NORTH AMERICA ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 89 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 90 US SLEEP DISORDERS STATISTICS (2021)
EXHIBIT 91 US ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 92 CHMS 2016–2017
EXHIBIT 93 CANADA: PREVALENCE OF SLEEP APNEA AMONG ADULTS AGED 18–79 YEARS
EXHIBIT 94 CANADA ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 95 EUROPE ANTI-SNORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 96 PREVALENCE OF OSA IN EUROPEAN COUNTRIES (2018)
EXHIBIT 97 EUROPE ANTI-SNORING DEVICES MARKET: KEY COUNTRIES
EXHIBIT 98 EUROPE ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 99 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 100 GERMANY ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 101 PREVALENCE OF OBESITY AMONG PEOPLE BETWEEN 8 AND 17 YEARS (2020)
EXHIBIT 102 PERCENTAGE OF PEOPLE IN DIFFERENT AGE GROUPS TREATED FOR OSA WITH CPAP (2009–2018)
EXHIBIT 103 FRANCE ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 104 UK OSA AND TREATMENT STATISTICS
EXHIBIT 105 UK ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 106 ITALY ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 107 SPAIN ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 108 APAC ANTI-SNORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 109 APAC ANTI-SNORING DEVICES MARKET: KEY COUNTRIES
EXHIBIT 110 APAC ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 111 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 112 CHINA ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 113 JAPAN ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 114 INDIA ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 115 SOUTH KOREA ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 116 AUSTRALIA’S OBESE & AGING POPULATION
EXHIBIT 117 SLEEP APNEA FACTS & FIGURES AUSTRALIA
EXHIBIT 118 AUSTRALIA ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 119 LATIN AMERICA ANTI-SNORING DEVICES MARKET: KEY COUNTRIES
EXHIBIT 120 LATIN AMERICA ANTI-SNORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 121 LATIN AMERICA ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 122 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 123 PERCENTAGE OF DIFFERENT AGE GROUP POPULATION
EXHIBIT 124 OVERWEIGHT & OBESITY STATISTICS BY NATIONAL HEALTH SURVEY (2019)
EXHIBIT 125 BRAZIL ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 126 MEXICO ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 127 ARGENTINA ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 128 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET: KEY COUNTRIES
EXHIBIT 129 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 130 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 131 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 132 TURKEY ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 133 SAUDI ARABIA ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 134 SOUTH AFRICA ANTI-SNORING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 135 GLOBAL ANTI-SNORING DEVICES MARKET: KEY VENDORS’ MARKET DOMINANCE ANALYSIS
EXHIBIT 136 KEY VENDORS IN GLOBAL ANTI-SNORING DEVICES MARKET: MARKET CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 137 RESMED: TOTAL REVENUE 2020–2022 ($ MILLION)
EXHIBIT 138 RESMED: R&D EXPENDITURE 2020–2022 ($ MILLION)
EXHIBIT 139 RESMED: TOTAL REVENUE SHARE BY BUSINESS SEGMENTS 2022 (%)
EXHIBIT 140 RESMED: GEOGRAPHY SHARE BY REGION 2022 (%)
EXHIBIT 141 KONINKLIJKE PHILIPS N. V.: TOTAL REVENUE 2019–2021 ($ BILLION)
EXHIBIT 142 KONINKLIJKE PHILIPS N. V.: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 143 KONINKLIJKE PHILIPS N. V.: REVENUE BY BUSINESS SEGMENTS 2021 (%)
EXHIBIT 144 FISHER & PAYKEL HEALTHCARE: TOTAL REVENUE 2020–2022 ($ MILLION)
EXHIBIT 145 FISHER & PAYKEL HEALTHCARE: R&D EXPENDITURE 2020–2022 ($ MILLION)
EXHIBIT 146 FISHER & PAYKEL HEALTHCARE: TOTAL REVENUE SHARE BY BUSINESS SEGMENTS 2022 (%)
EXHIBIT 147 FISHER & PAYKEL HEALTHCARE: GEOGRAPHY SHARE BY SEGMENT 2022 (%)

LIST OF TABLES

TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015–2021
TABLE 3 GLOBAL ANTI-SNORING DEVICES MARKET BY ORAL DEVICES 2021–2027 ($ MILLION)
TABLE 4 GLOBAL ANTI-SNORING DEVICES MARKET BY ORAL DEVICES 2021–2027 (%)
TABLE 5 POPULAR CPAP DEVICES
TABLE 6 GLOBAL ANTI-SNORING DEVICE MARKET BY PAP DEVICES 2021–2027 ($ MILLION)
TABLE 7 GLOBAL ANTI-SNORING DEVICE MARKET BY PAP DEVICES 2021–2027 (%)
TABLE 8 GLOBAL ANTI-SNORING DEVICES MARKET BY NASAL DEVICES 2021–2027 ($ MILLION)
TABLE 9 GLOBAL ANTI-SNORING DEVICES MARKET BY NASAL DEVICES 2021–2027 (%)
TABLE 10 GLOBAL ANTI-SNORING DEVICES MARKET BY OTHERS 2021–2027 ($ MILLION)
TABLE 11 GLOBAL ANTI-SNORING DEVICES MARKET BY OTHERS 2021–2027 (%)
TABLE 12 GLOBAL ANTI-SNORING DEVICES MARKET BY BETWEEN 40 & 59 YEARS 2021–2027 ($ MILLION)
TABLE 13 GLOBAL ANTI-SNORING DEVICES MARKET BY BETWEEN 40 & 59 YEARS 2021–2027 (%)
TABLE 14 GLOBAL ANTI-SNORING DEVICES MARKET BY 60 YEARS & ABOVE 2021–2027 ($ MILLION)
TABLE 15 GLOBAL ANTI-SNORING DEVICES MARKET BY 60 YEARS & ABOVE 2021–2027 (%)
TABLE 16 GLOBAL ANTI-SNORING DEVICES MARKET BY BELOW 40 YEARS 2021–2027 ($ MILLION)
TABLE 17 GLOBAL ANTI-SNORING DEVICES MARKET BY BELOW 40 YEARS 2021–2027 (%)
TABLE 18 SLEEP DISORDER & SYMPTOM STATISTICS: NORTHWEST ADELAIDE HEALTH STUDY (NWAHS) PARTICIPANTS
TABLE 19 GLOBAL ANTI-SNORING DEVICES MARKET BY MEN 2021–2027 ($ MILLION)
TABLE 20 GLOBAL ANTI-SNORING DEVICES MARKET BY MEN 2021–2027 (%)
TABLE 21 GLOBAL ANTI-SNORING DEVICES MARKET BY WOMEN 2021–2027 ($ MILLION)
TABLE 22 GLOBAL ANTI-SNORING DEVICES MARKET BY WOMEN 2021–2027 (%)
TABLE 23 GLOBAL ANTI-SNORING DEVICES MARKET BY SLEEP LABS & DENTAL CLINICS 2021–2027 ($ MILLION)
TABLE 24 GLOBAL ANTI-SNORING DEVICES MARKET BY SLEEP LABS & DENTAL CLINICS 2021–2027 (%)
TABLE 25 GLOBAL ANTI-SNORING DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021–2027 ($ MILLION)
TABLE 26 GLOBAL ANTI-SNORING DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021–2027 (%)
TABLE 27 GLOBAL ANTI-SNORING DEVICES MARKET BY HOSPITALS 2021–2027 ($ MILLION)
TABLE 28 GLOBAL ANTI-SNORING DEVICES MARKET BY HOSPITALS 2021–2027 (%)
TABLE 29 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 30 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 (%)
TABLE 31 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 ($ MILLION)
TABLE 32 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 (%)
TABLE 33 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 34 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 35 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 36 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 37 EUROPE ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 38 EUROPE ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 (%)
TABLE 39 EUROPE ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 ($ MILLION)
TABLE 40 EUROPE ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 (%)
TABLE 41 EUROPE ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 42 EUROPE ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 43 EUROPE ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 44 EUROPE ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 45 APAC ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 46 APAC ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 (%)
TABLE 47 APAC ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 ($ MILLION)
TABLE 48 APAC ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 (%)
TABLE 49 APAC ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 50 APAC ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 51 APAC ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 52 APAC ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 53 PREVALENCE OF HIGH RISK FOR OSA ACCORDING TO SOCIO-DEMOGRAPHIC CHARACTERISTICS & COMORBIDITY (N = 2,740)
TABLE 54 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 55 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 (%)
TABLE 56 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 ($ MILLION)
TABLE 57 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 (%)
TABLE 58 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 59 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 60 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 61 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 62 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 63 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 (%)
TABLE 64 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 ($ MILLION)
TABLE 65 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 (%)
TABLE 66 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 67 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 68 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 69 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 70 APNEA SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 71 RESMED: MAJOR PRODUCT OFFERINGS
TABLE 72 KONINKLIJKE PHILIPS N.V.: MAJOR PRODUCT OFFERINGS
TABLE 73 FISHER & PAYKEL HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 74 TOMED: MAJOR PRODUCT OFFERINGS
TABLE 75 ILLUSION ALIGNERS: MAJOR PRODUCT OFFERINGS
TABLE 76 SLEEP NUMBER: MAJOR PRODUCT OFFERINGS
TABLE 77 VVFLY ELECTRONICS: MAJOR PRODUCT OFFERINGS
TABLE 78 SIGNIFIER MEDICAL TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 79 GLIDEWELL: MAJOR PRODUCT OFFERINGS
TABLE 80 SMART NORA: MAJOR PRODUCT OFFERINGS
TABLE 81 PROSOMNUS: MAJOR PRODUCT OFFERINGS
TABLE 82 SOMNOMED: MAJOR PRODUCT OFFERINGS
TABLE 83 REM-FIT: MAJOR PRODUCT OFFERINGS
TABLE 84 DOWNTOWN DENVER SLEEP SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 85 MEDITAS: MAJOR PRODUCT OFFERINGS
TABLE 86 APNEAMED: MAJOR PRODUCT OFFERINGS
TABLE 87 WOLFSON HOLDCO: MAJOR PRODUCT OFFERINGS
TABLE 88 RHINOMED: MAJOR PRODUCT OFFERINGS
TABLE 89 DEVILBISS HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 90 WHITE DENTAL HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 91 HÜPNOS: MAJOR PRODUCT OFFERINGS
TABLE 92 NITETRONIC: MAJOR PRODUCT OFFERINGS
TABLE 93 NYXOAH: MAJOR PRODUCT OFFERINGS
TABLE 94 OVENTUS: MAJOR PRODUCT OFFERINGS
TABLE 95 VIVOS THERAPEUTICS: MAJOR PRODUCT OFFERINGS
TABLE 96 OVENTUS: MAJOR PRODUCT OFFERINGS
TABLE 97 ZQUIET: MAJOR PRODUCT OFFERINGS
TABLE 98 REMSLEEP HOLDINGS: MAJOR PRODUCT OFFERINGS
TABLE 99 HUMETRON: MAJOR PRODUCT OFFERINGS
TABLE 100 NIDRA CARE: MAJOR PRODUCT OFFERINGS
TABLE 101 GLOBAL ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 102 GLOBAL ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 (%)
TABLE 103 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 104 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 (%)
TABLE 105 EUROPE ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 106 EUROPE ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 (%)
TABLE 107 APAC ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 108 APAC ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 (%)
TABLE 109 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 110 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 (%)
TABLE 111 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 112 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY PRODUCT 2021–2027 (%)
TABLE 113 GLOBAL ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 ($ MILLION)
TABLE 114 GLOBAL ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 (%)
TABLE 115 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 ($ MILLION)
TABLE 116 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 (%)
TABLE 117 EUROPE ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 ($ MILLION)
TABLE 118 EUROPE ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 (%)
TABLE 119 APAC ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 ($ MILLION)
TABLE 120 APAC ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 (%)
TABLE 121 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 ($ MILLION)
TABLE 122 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 (%)
TABLE 123 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 ($ MILLION)
TABLE 124 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY AGE 2021–2027 (%)
TABLE 125 GLOBAL ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 126 GLOBAL ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 127 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 128 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 129 EUROPE ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 130 EUROPE ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 131 APAC ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 132 APAC ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 133 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 134 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 135 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 136 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 137 GLOBAL ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 138 GLOBAL ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 139 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 140 NORTH AMERICA ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 141 EUROPE ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 142 EUROPE ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 143 APAC ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 144 APAC ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 145 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 146 LATIN AMERICA ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 147 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 148 MIDDLE EAST & AFRICA ANTI-SNORING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 149 GLOBAL ANTI-SNORING DEVICES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 150 GLOBAL ANTI-SNORING DEVICES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 151 GLOBAL ANTI-SNORING DEVICES MARKET BY ORAL DEVICES 2021–2027 ($ MILLION)
TABLE 152 GLOBAL ANTI-SNORING DEVICES MARKET BY ORAL DEVICES 2021–2027 (%)
TABLE 153 GLOBAL ANTI-SNORING DEVICES MARKET BY PAP DEVICES 2021–2027 ($ MILLION)
TABLE 154 GLOBAL ANTI-SNORING DEVICES MARKET BY PAP DEVICES 2021–2027 (%)
TABLE 155 GLOBAL ANTI-SNORING DEVICES MARKET BY NASAL DEVICES 2021–2027 ($ MILLION)
TABLE 156 GLOBAL ANTI-SNORING DEVICES MARKET BY NASAL DEVICES 2021–2027 (%)
TABLE 157 GLOBAL ANTI-SNORING DEVICES MARKET BY OTHERS 2021–2027 ($ MILLION)
TABLE 158 GLOBAL ANTI-SNORING DEVICES MARKET BY OTHERS 2021–2027 (%)
TABLE 159 GLOBAL ANTI-SNORING DEVICES MARKET BY BETWEEN 40 & 59 YEARS 2021–2027 ($ MILLION)
TABLE 160 GLOBAL ANTI-SNORING DEVICES MARKET BY BETWEEN 40 & 59 YEARS 2021–2027 (%)
TABLE 161 GLOBAL ANTI-SNORING DEVICES MARKET BY 60 YEARS & ABOVE 2021–2027 ($ MILLION)
TABLE 162 GLOBAL ANTI-SNORING DEVICES MARKET BY 60 YEARS & ABOVE 2021–2027 (%)
TABLE 163 GLOBAL ANTI-SNORING DEVICES MARKET BY BELOW 40 YEARS 2021–2027 ($ MILLION)
TABLE 164 GLOBAL ANTI-SNORING DEVICES MARKET BY BELOW 40 YEARS 2021–2027 (%)
TABLE 165 GLOBAL ANTI-SNORING DEVICES MARKET BY MEN 2021–2027 ($ MILLION)
TABLE 166 GLOBAL ANTI-SNORING DEVICES MARKET BY MEN 2021–2027 (%)
TABLE 167 GLOBAL ANTI-SNORING DEVICES MARKET BY WOMEN 2021–2027 ($ MILLION)
TABLE 168 GLOBAL ANTI-SNORING DEVICES MARKET BY WOMEN 2021–2027 (%)
TABLE 169 GLOBAL ANTI-SNORING DEVICES MARKET BY SLEEP LABS & DENTAL CLINICS 2021–2027 ($ MILLION)
TABLE 170 GLOBAL ANTI-SNORING DEVICES MARKET BY SLEEP LABS & DENTAL CLINICS 2021–2027 (%)
TABLE 171 GLOBAL ANTI-SNORING DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021–2027 ($ MILLION)
TABLE 172 GLOBAL ANTI-SNORING DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021–2027 (%)
TABLE 173 GLOBAL ANTI-SNORING DEVICES MARKET BY HOSPITALS 2021–2027 ($ MILLION)
TABLE 174 GLOBAL ANTI-SNORING DEVICES MARKET BY HOSPITALS 2021–2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date